Earnings History Data for Akari Therapeutics Plc (AKTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Akari Therapeutics Plc

Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
22-09-2021 PM AKTX Akari Therapeutics Plc 86.15 -0.11 0.00 -0.28 Akari Therapeutics reports Q2 results
[9/22/2021 8:43 AM]
1.72 -0.04 
1.81 0.05 
1.42 - 4.21 99,634 110,000 1,101
11-12-2020 PM 8:30 AM ET
(Dec 11)
AKTX Akari Therapeutics Plc 73.10 0.04 0.00 -0.14 Akari Therapeutics reports Q3 results
[12/11/2020 11:35 AM]
2.01 0.07 
1.95 0.01 
0.87 - 2.79 320,684 430,800 7,271